Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Volume 22, 2021 - Issue sup1: Assessments of Pulmonary Function in patients with Amyotrophic Lateral Sclerosis: Options and Applicability in both the clinical care and clinical trial settings
Submit an article Journal homepage
1,651
Views
5
CrossRef citations to date
0
Altmetric
Research Articles

Development and validation of a machine-learning ALS survival model lacking vital capacity (VC-Free) for use in clinical trials during the COVID-19 pandemic

Danielle Beaulieu1 Origent Data Sciences, Inc, Vienna, VA, USAView further author information
,
James D. Berry2 Sean M. Healey & AMG Center for ALS and Neurological Clinical Research Institute, Massachusetts General Hospital, Boston, MA, USAView further author information
,
Sabrina Paganoni2 Sean M. Healey & AMG Center for ALS and Neurological Clinical Research Institute, Massachusetts General Hospital, Boston, MA, USAView further author information
,
Jonathan D. Glass3 Department of Neurology, Emory University School of Medicine Atlanta, Atlanta, GAUSAView further author information
,
Christina Fournier3 Department of Neurology, Emory University School of Medicine Atlanta, Atlanta, GAUSAView further author information
,
Jonavelle Cuerdo1 Origent Data Sciences, Inc, Vienna, VA, USAView further author information
,
Mark Schactman1 Origent Data Sciences, Inc, Vienna, VA, USAView further author information
&
David L. Ennist1 Origent Data Sciences, Inc, Vienna, VA, USACorrespondence[email protected]
View further author information
 show all
Pages 22-32 | Received 23 Nov 2020, Accepted 27 Apr 2021, Published online: 04 Aug 2021

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Shiran Salomon-Zimri, Avital Pushett, Niva Russek-Blum, Ruben P. A. Van Eijk, Nurit Birman, Beatrice Abramovich, Erez Eitan, Katya Elgrart, Danielle Beaulieu, David L. Ennist, James D. Berry, Sabrina Paganoni, Jeremy M. Shefner & Vivian E. Drory. (2023) Combination of ciprofloxacin/celecoxib as a novel therapeutic strategy for ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:3-4, pages 263-271.
Read now

Articles from other publishers (4)

Scott Askin, Denis Burkhalter, Gilda Calado & Samar El Dakrouni. (2023) Artificial Intelligence Applied to clinical trials: opportunities and challenges. Health and Technology 13:2, pages 203-213.
Crossref
Shelagh K. Genuis, Westerly Luth, Tania Bubela & Wendy S. Johnston. (2022) Covid-19 threat and coping: application of protection motivation theory to the pandemic experiences of people affected by amyotrophic lateral sclerosis. BMC Neurology 22:1.
Crossref
Christina N. Fournier. (2022) Considerations for Amyotrophic Lateral Sclerosis (ALS) Clinical Trial Design. Neurotherapeutics 19:4, pages 1180-1192.
Crossref
Peter Bede, Aizuri Murad, Jasmin Lope, Stacey Li Hi Shing, Eoin Finegan, Rangariroyashe H. Chipika, Orla Hardiman & Kai Ming Chang. (2022) Phenotypic categorisation of individual subjects with motor neuron disease based on radiological disease burden patterns: A machine-learning approach. Journal of the Neurological Sciences 432, pages 120079.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.